WST · West Pharmaceutical Services Inc · Webcasts, Transcripts & Audio
$416.42
+5.12 (+1.24%)
At close · Nov 13
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Market Cap
$29.01B
Shares
69.66M
Volume · Nov 13
479.1K
Avg daily vol (3M)
601.93K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
West Pharmaceutical Services Inc Webcasts
Earnings calls, investor updates, investor days and conferences for West Pharmaceutical Services Inc (WST), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.
Pull transcripts and briefs through the earnings call transcript API or MCP →
Add these events to your calendar (.ics)
Conference
Investor event
2026-11-18
West Pharmaceutical Services Inc (WST) November 18, 2026 Conference
Scheduled
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q3
2026-10-29
West Pharmaceutical Services Inc (WST) Q3 2026 Earnings Call Transcript
Confident tone
Margin expansion and EPS growth
Continuous improvement and customer relationships
Capacity expansion and capital investment
Revenue
$874.50M
▲ 8.7% YoY Diluted EPS
$3.02
▲ 57.3% YoY Gross margin
39.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-09-14
West Pharmaceutical Services Inc (WST) September 14, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Conference
Investor event
2026-09-10
West Pharmaceutical Services Inc (WST) September 10, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q2
2026-07-23
West Pharmaceutical Services Inc (WST) Q2 2026 Earnings Call Transcript
Confident tone
Proprietary Products / HVP Components Growth
GLP-1 Demand
Annex 1 / HVP Upgrade Mix Shift
Revenue
$872.30M
▲ 13.8% YoY Diluted EPS
$2.15
▲ 18.1% YoY Gross margin
37.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-06-02
West Pharmaceutical Services Inc (WST) June 2, 2026 Conference
No reported result — non-financial event
Audio
Transcript
Slides
Conference
Investor event
2026-05-12
West Pharmaceutical Services Inc (WST) May 12, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q1
2026-04-23
West Pharmaceutical Services Inc (WST) Q1 2026 Earnings Call Transcript
Confident tone
HVP Components / Proprietary Products
Contract-Manufactured Products (West Vantage)
GLP-1 and Orals Market
Revenue
$844.90M
▲ 21% YoY Diluted EPS
$1.92
▲ 56.1% YoY Gross margin
35.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-02-12
West Pharmaceutical Services Inc (WST) Q4 2025 Earnings Call Transcript
Confident tone
Proprietary Products / HVP components growth
GLP-1 market dynamics
Capacity expansion and tech transfers
Revenue
$805.00M*
▲ 7.5% YoY Gross margin
37.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-10-23
West Pharmaceutical Services Inc (WST) Q3 2025 Earnings Call Transcript
Confident tone
Organic revenue growth and raised guidance
Annex 1 regulatory upgrade opportunity
HVP components / proprietary segment strength
Revenue
$804.60M
▲ 7.7% YoY Diluted EPS
$1.92
▲ 3.8% YoY Gross margin
36.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-07-24
West Pharmaceutical Services Inc (WST) Q2 2025 Earnings Call Transcript
Confident tone
HVP Components and GLP-1 Growth
Annex-1 Opportunity
SmartDose and HVP Delivery Devices
Revenue
$766.50M
▲ 9.2% YoY Diluted EPS
$1.82
▲ 20.5% YoY Gross margin
35.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-04-24
West Pharmaceutical Services Inc (WST) Q1 2025 Earnings Call Transcript
Positive tone
Proprietary Products / HVP components
Biologics destocking and recovery
Contract-manufactured products
Revenue
$698.00M
▲ 0.4% YoY Diluted EPS
$1.23
▼ 20.6% YoY Gross margin
33.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-02-13
West Pharmaceutical Services Inc (WST) Q4 2024 Earnings Call Transcript
Positive tone
GLP-1 market growth
HPP components and biologics
Contract manufacturing strategy shift
Revenue
$748.80M*
▲ 2.3% YoY Gross margin
36.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-10-24
West Pharmaceutical Services Inc (WST) Q3 2024 Earnings Call Transcript
Positive tone
Biologics and HVP
De-stocking normalization
Drug delivery devices ramp
Revenue
$746.90M
▼ 0.1% YoY Diluted EPS
$1.85
▼ 13.6% YoY Gross margin
35.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-07-25
West Pharmaceutical Services Inc (WST) Q2 2024 Earnings Call Transcript
Cautious tone
Proprietary Products and Biologics
Customer destocking and order patterns
Capacity expansion and capital projects
Revenue
$702.10M
▼ 6.9% YoY Diluted EPS
$1.51
▼ 26.7% YoY Gross margin
32.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-04-25
West Pharmaceutical Services Inc (WST) Q1 2024 Earnings Call Transcript
Positive tone
Customer destocking and inventory management
Contract Manufacturing / GLP-1 demand
HVP components and devices (Proprietary Products)
Revenue
$695.40M
▼ 3% YoY Diluted EPS
$1.55
▼ 16.2% YoY Gross margin
33.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-02-15
West Pharmaceutical Services Inc (WST) Q4 2023 Earnings Call Transcript
Cautious tone
Capital expenditure deployment
HVP (High-Value Product) capacity expansion
2024 guidance reduction and headwinds
Revenue
$732.00M*
▲ 3.3% YoY Gross margin
38.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-10-26
West Pharmaceutical Services Inc (WST) Q3 2023 Earnings Call Transcript
Revenue
$747.40M
▲ 8.8% YoY Diluted EPS
$2.14
▲ 34.6% YoY Gross margin
38.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-07-27
West Pharmaceutical Services Inc (WST) Q2 2023 Earnings Call Transcript
Revenue
$753.80M
▼ 2.3% YoY Diluted EPS
$2.06
▼ 16.9% YoY Gross margin
38.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-04-27
West Pharmaceutical Services Inc (WST) Q1 2023 Earnings Call Transcript
Revenue
$716.60M
▼ 0.5% YoY Diluted EPS
$1.85
▼ 19.2% YoY Gross margin
37.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-02-16
West Pharmaceutical Services Inc (WST) Q4 2022 Earnings Call Transcript
Revenue
$708.70M*
▼ 3% YoY Gross margin
37.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-10-27
West Pharmaceutical Services Inc (WST) Q3 2022 Earnings Call Transcript
Revenue
$686.90M
▼ 2.8% YoY Diluted EPS
$1.59
▼ 31.2% YoY Gross margin
39.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-07-28
West Pharmaceutical Services Inc (WST) Q2 2022 Earnings Call Transcript
Revenue
$771.30M
▲ 6.6% YoY Diluted EPS
$2.48
▲ 0.4% YoY Gross margin
41.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-04-28
West Pharmaceutical Services Inc (WST) Q1 2022 Earnings Call Transcript
Revenue
$720.00M
▲ 7.4% YoY Diluted EPS
$2.29
▲ 15.1% YoY Gross margin
39.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-02-17
West Pharmaceutical Services Inc (WST) Q4 2021 Earnings Call Transcript
Revenue
$730.80M*
▲ 26% YoY Gross margin
41.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-10-28
West Pharmaceutical Services Inc (WST) Q3 2021 Earnings Call Transcript
Revenue
$706.50M
▲ 28.9% YoY Diluted EPS
$2.31
▲ 111.9% YoY Gross margin
40.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-07-29
West Pharmaceutical Services Inc (WST) Q2 2021 Earnings Call Transcript
Revenue
$723.60M
▲ 37.3% YoY Diluted EPS
$2.47
▲ 104.1% YoY Gross margin
43.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2021-04-29
West Pharmaceutical Services Inc (WST) Q1 2021 Earnings Call Transcript
Revenue
$670.70M
▲ 36.5% YoY Diluted EPS
$1.99
▲ 101% YoY Gross margin
40.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2021-02-18
West Pharmaceutical Services Inc (WST) Q4 2020 Earnings Call Transcript
Revenue
$580.20M
▲ 23.3% YoY Diluted EPS
$1.29
▲ 53.6% YoY Gross margin
36.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q3
2020-10-22
West Pharmaceutical Services Inc (WST) Q3 2020 Earnings Call Transcript
Revenue
$548.00M
▲ 20.1% YoY Diluted EPS
$1.09
▲ 45.3% YoY Gross margin
35.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q2
2020-07-23
West Pharmaceutical Services Inc (WST) Q2 2020 Earnings Call Transcript
Revenue
$527.20M
▲ 12.2% YoY Diluted EPS
$1.21
▲ 37.5% YoY Gross margin
37.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q1
2020-04-23
West Pharmaceutical Services Inc (WST) Q1 2020 Earnings Call Transcript
Revenue
$491.50M
▲ 10.8% YoY Diluted EPS
$0.99
▲ 35.6% YoY Gross margin
34.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY19 · Q4
2020-02-13
West Pharmaceutical Services Inc (WST) Q4 2019 Earnings Call
Revenue
$470.60M
▲ 11.4% YoY Diluted EPS
$0.84
Gross margin
32.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Showing 1–33 of 33 webcasts
Key facts
CIK
105770
CUSIP
955306105
13F (30d)
703 filings
642 filers
Visit website
Investor relations